Michael Rome
Director/Miembro de la Junta en Remix Therapeutics, Inc. .
Cargos activos de Michael Rome
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2021 | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
Historial de carrera de Michael Rome
Antiguos cargos conocidos de Michael Rome.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KINNATE BIOPHARMA INC. | Director/Miembro de la Junta | 01/12/2019 | 03/04/2024 |
Independent Dir/Board Member | 01/12/2019 | 03/04/2024 | |
THESEUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/01/2021 | 14/02/2024 |
Independent Dir/Board Member | 01/01/2021 | 14/02/2024 | |
FS DEVELOPMENT CORP. | Director/Miembro de la Junta | 01/06/2020 | 01/02/2021 |
Corporate Officer/Principal | 01/06/2020 | 01/02/2021 | |
PHARVARIS N.V. | Director/Miembro de la Junta | 01/01/2019 | 31/12/2020 |
PARDES BIOSCIENCES, INC. | Director/Miembro de la Junta | 01/08/2020 | - |
Corporate Officer/Principal | 01/08/2020 | - |
Formación de Michael Rome.
University of California, Los Angeles | Undergraduate Degree |
California Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Países Bajos | 2 |
Operativa
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sectorial
Health Technology | 5 |
Finance | 4 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PHARVARIS N.V. | Health Technology |
Empresas privadas | 6 |
---|---|
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
FS Development Corp.
FS Development Corp. Financial ConglomeratesFinance FS Development Corp. operates as a blank check company. It is for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Jim Tananbaum in June 2020 and is headquartered in San Francisco, CA. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
FS Development Corp. II
FS Development Corp. II Financial ConglomeratesFinance FS Development Corp. II is a blank check company, which formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more entities. The company was founded by James B. Tananbaum on August 21, 2020 and is headquartered in Larkspur, CA. | Finance |
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Finance |
- Bolsa de valores
- Insiders
- Michael Rome
- Experiencia